(QLTY) The 2023 Series Trust II - Ratings and Ratios
Equity, Stocks, ETF, U.S., Quality
| Risk via 10d forecast | |
|---|---|
| Volatility | 15.4% |
| Value at Risk 5%th | 25.9% |
| Relative Tail Risk | 2.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.58 |
| Alpha | 2.73 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.395 |
| Beta | 0.868 |
| Beta Downside | 0.849 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.00% |
| Mean DD | 1.95% |
| Median DD | 0.88% |
Description: QLTY The 2023 Series Trust II November 11, 2025
The 2023 ETF Series Trust II (NASDAQ: QLTY) is an actively managed U.S. equity ETF that aims to invest in high-quality companies identified by its adviser, Grantham, Mayo, Van Otterloo & Co. (GMO). Its holdings are primarily common and preferred stocks, with secondary exposure to convertible securities, ADRs, equity REITs, income trusts, and equity-focused investment-company securities. The fund is classified as a “Large Blend” ETF, indicating a mix of growth and value large-cap U.S. equities.
Key quantitative metrics (as of the most recent quarterly filing) include an expense ratio of 0.55 %, total assets under management of roughly $210 million, and an average portfolio turnover of 45 % annually-higher than passive large-cap ETFs but comparable to other active managers. The fund’s top sector allocations are technology (≈28 %), consumer discretionary (≈22 %), and health care (≈15 %). Its performance has historically correlated with U.S. earnings growth and is sensitive to Federal Reserve policy; a 100-basis-point rise in rates typically depresses large-cap valuations by 0.8-1.2 % on average, a risk the manager mitigates by favoring companies with strong balance sheets and cash flow generation.
If you’re interested in a data-driven assessment of how QLTY’s quality-tilt aligns with broader market dynamics, a quick look at ValueRay’s proprietary scoring model can provide additional insight into the fund’s underlying holdings.
QLTY ETF Overview
| Market Cap in USD | 2,756m |
| Category | Large Blend |
| TER | 0.50% |
| IPO / Inception | 2023-11-13 |
| Return 12m vs S&P 500 | 1.47% |
| Analyst Rating | - |
QLTY Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 0.80% |
| Yield on Cost 5y | 1.16% |
| Yield CAGR 5y | 519.51% |
| Payout Consistency | 83.3% |
| Payout Ratio | - |
QLTY Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 20.80% |
| CAGR/Max DD Calmar Ratio | 1.22 |
| CAGR/Mean DD Pain Ratio | 10.68 |
| Current Volume | 402.8k |
| Average Volume | 176.9k |
What is the price of QLTY shares?
Over the past week, the price has changed by -2.47%, over one month by -2.29%, over three months by +5.14% and over the past year by +13.50%.
Is QLTY a buy, sell or hold?
What are the forecasts/targets for the QLTY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 41 | 13% |
QLTY Fundamental Data Overview November 19, 2025
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.76b USD (2.76b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.76b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.76b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.22% (E(2.76b)/V(2.76b) * Re(9.22%) + (debt-free company))
Discount Rate = 9.22% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for QLTY ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle